Klass Russell Kevin's Form 4 filing
Zomedica Corp. (ZOMDF) · filed Jun 12, 2024
- Accession no.
- 0001654954-24-007663
- Filed
- Jun 12, 2024, 4:15 PM ET
- Trade date
- Jun 10-11, 2024
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 2 non-derivative transactions. Open-market purchases total $105.0K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Klass Russell KevinCIK 0001999774 | Officer (Vice President of Sales) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jun 10, 2024 | Common Stock, without par value | PPurchaseAcquired | +200,007 | $0.1497F1 | +$29,941.05 | 1,200,057 | Direct | |
| Jun 11, 2024 | Common Stock, without par value | PPurchaseAcquired | +500,000 | $0.1502F2 | +$75,100 | 1,700,057 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
The price reported is the weighted average price. These shares were sold in multiple transactions ranging from $0.1495 to $0.1499, inclusive. The reporting person undertakes to provide to Zomedica Corp., any security holder of Zomedica Corp., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in the preceding sentence.
Referenced by the price of 1 transaction in Table I.
- F2
The price reported is the weighted average price. These shares were sold in multiple transactions ranging from $0.1485 to $0.1526, inclusive. The reporting person undertakes to provide to Zomedica Corp., any security holder of Zomedica Corp., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in the preceding sentence.
Referenced by the price of 1 transaction in Table I.